SCHEMBL19669735

SCHEMBL19669735

CC(C)(I)NC(=O)/C=C/CN1CCC(N2CCOCC2)CC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CDK7 P50613 3/20 0.34
CDK13 Q14004 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL3 Q96JM7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LMNA P02545 1/20 0.34
HTR7 P34969 1/20 0.33
BTK Q06187 1/20 0.32
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
USP5 P45974 1/20 0.31
GNRHR P30968 1/20 0.31
EPHX2 P34913 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19669736 0.87 MEN1 (0.45) KDM4EALDH1A1MEN1KMT2ACDK7
SCHEMBL19669737 0.86 EGFR (0.32) EGFRERBB2
SCHEMBL15600964 0.85 KDM4E (0.41) KDM4EALDH1A1CDK7CDK13L3MBTL3
SCHEMBL19669759 0.76 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2BTK
SCHEMBL15600841 0.76 SMN1; SMN2 (0.53) KDM4EALDH1A1MEN1KMT2ACDK7
SCHEMBL24637164 0.76 SIGMAR1 (0.36) EGFRERBB2
SCHEMBL18030989 0.76 EGFR (0.33) EGFRERBB2
SCHEMBL20235763 0.72 ACKR3 (0.35) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL19442310 0.72 MEN1 (0.43) KDM4EALDH1A1MEN1KMT2ACDK7
SCHEMBL19669934 0.72 SIGMAR1 (0.39) KDM4EEGFRHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834571-B2 Compounds for inhibiting cell proliferation in EGFR-driven cancers ARIAD PHARMACEUTICALS, INC. (US) 2017-12-05 US disclosed